Laboratory Medicine ›› 2024, Vol. 39 ›› Issue (10): 933-938.DOI: 10.3969/j.issn.1673-8640.2024.10.002
Previous Articles Next Articles
MENG Qiang, WANG Shuang, BAI Zhou, HUANG Qian, FU Yang
Received:2023-09-12
Revised:2024-05-16
Online:2024-10-30
Published:2024-11-08
CLC Number:
MENG Qiang, WANG Shuang, BAI Zhou, HUANG Qian, FU Yang. Role of TLR9 of red blood cell membrane surface in sepsis patients with anemia[J]. Laboratory Medicine, 2024, 39(10): 933-938.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2024.10.002
| 组别 | 例数 | RBC计数/(×1012·L-1) | Hb/(g·L-1) | MCV/fL | MCH/pg |
|---|---|---|---|---|---|
| 脓毒症组 | 237 | 3.23(2.64~3.79)***### | 96(79~113)***### | 96.5(91.5~101.7)***## | 30.4(28.8~31.5) |
| 普通感染组 | 241 | 3.61(2.90~4.18)*** | 106(88~128)*** | 95.0(91.2~98.6) | 30.4(29.2~31.6) |
| 正常对照组 | 206 | 4.78(4.48~5.06) | 145(134~155) | 94.2(92.3~96.3) | 30.4(29.7~31.2) |
| 组别 | MCHC/(g·L-1) | RDW-SD/fL | RDW-CV/% | RET%/% | |
| 脓毒症组 | 308(292~321)***### | 52.0(47.8~57.4)***### | 14.9(13.8~16.7)***# | 1.82(1.18~2.81)* | |
| 普通感染组 | 319(311~329)** | 50.1(45.8~56.0)*** | 14.6(13.4~16.6)*** | 1.85(1.33~2.75)*** | |
| 正常对照组 | 322(318-326) | 44.2(42.5~46.1) | 12.7(12.4~13.2) | 1.59(1.39~1.85) | |
| 组别 | RET#/(×109·L-1) | IRF/% | LFR/% | MFR/% | |
| 脓毒症组 | 57.6(36.1~90.4)***## | 14.4(9.50~23.00)*** | 85.6(77.0~90.5)*** | 11.4(8.2~14.6)*** | |
| 普通感染组 | 71.1(46.7~95.5)* | 13.4(8.45~20.25)*** | 86.6(79.8~91.6)*** | 10.8(7.2~13.8)*** | |
| 正常对照组 | 77.4(64.0~89.7) | 9.30(7.60~11.82) | 90.7(88.2~92.4) | 8.4(6.7~10.3) | |
| 组别 | HFR/% | RET-He/pg | RBC-O(×1012·L-1) | RBC-He/pg | |
| 脓毒症组 | 2.6(1.3~8.3)***# | 30.8(27.9~32.5)***# | 3.21(2.61~3.74)***### | 29.7(28.2~30.8)*** | |
| 普通感染组 | 2.1(1.0~6.5)*** | 31.7(28.6~33.7)*** | 3.53(2.83~4.14)*** | 29.7(28.4~31.0)*** | |
| 正常对照组 | 1.0(0.6~1.6) | 34.1(33.3~34.9) | 4.76(4.47~5.02) | 31.0(30.4~31.7) | |
| 组别 | RET-Y | RET-RBC-Y | IRF-Y | ||
| 脓毒症组 | 173.8(163.5~179.1)***# | 169.9(164.9~173.9)*** | 170.3(157.4~180.5)*** | ||
| 普通感染组 | 176.6(166.1~182.7)*** | 170.0(165.5~174.5)*** | 173.4(162.7~180.9)*** | ||
| 正常对照组 | 184.1(181.7~186.4) | 174.3(172.4~176.6) | 183.5(180.3~186.1) | ||
| 组别 | 例数 | RBC计数/(×1012·L-1) | Hb/(g·L-1) | MCV/fL | MCH/pg |
|---|---|---|---|---|---|
| 脓毒症组 | 237 | 3.23(2.64~3.79)***### | 96(79~113)***### | 96.5(91.5~101.7)***## | 30.4(28.8~31.5) |
| 普通感染组 | 241 | 3.61(2.90~4.18)*** | 106(88~128)*** | 95.0(91.2~98.6) | 30.4(29.2~31.6) |
| 正常对照组 | 206 | 4.78(4.48~5.06) | 145(134~155) | 94.2(92.3~96.3) | 30.4(29.7~31.2) |
| 组别 | MCHC/(g·L-1) | RDW-SD/fL | RDW-CV/% | RET%/% | |
| 脓毒症组 | 308(292~321)***### | 52.0(47.8~57.4)***### | 14.9(13.8~16.7)***# | 1.82(1.18~2.81)* | |
| 普通感染组 | 319(311~329)** | 50.1(45.8~56.0)*** | 14.6(13.4~16.6)*** | 1.85(1.33~2.75)*** | |
| 正常对照组 | 322(318-326) | 44.2(42.5~46.1) | 12.7(12.4~13.2) | 1.59(1.39~1.85) | |
| 组别 | RET#/(×109·L-1) | IRF/% | LFR/% | MFR/% | |
| 脓毒症组 | 57.6(36.1~90.4)***## | 14.4(9.50~23.00)*** | 85.6(77.0~90.5)*** | 11.4(8.2~14.6)*** | |
| 普通感染组 | 71.1(46.7~95.5)* | 13.4(8.45~20.25)*** | 86.6(79.8~91.6)*** | 10.8(7.2~13.8)*** | |
| 正常对照组 | 77.4(64.0~89.7) | 9.30(7.60~11.82) | 90.7(88.2~92.4) | 8.4(6.7~10.3) | |
| 组别 | HFR/% | RET-He/pg | RBC-O(×1012·L-1) | RBC-He/pg | |
| 脓毒症组 | 2.6(1.3~8.3)***# | 30.8(27.9~32.5)***# | 3.21(2.61~3.74)***### | 29.7(28.2~30.8)*** | |
| 普通感染组 | 2.1(1.0~6.5)*** | 31.7(28.6~33.7)*** | 3.53(2.83~4.14)*** | 29.7(28.4~31.0)*** | |
| 正常对照组 | 1.0(0.6~1.6) | 34.1(33.3~34.9) | 4.76(4.47~5.02) | 31.0(30.4~31.7) | |
| 组别 | RET-Y | RET-RBC-Y | IRF-Y | ||
| 脓毒症组 | 173.8(163.5~179.1)***# | 169.9(164.9~173.9)*** | 170.3(157.4~180.5)*** | ||
| 普通感染组 | 176.6(166.1~182.7)*** | 170.0(165.5~174.5)*** | 173.4(162.7~180.9)*** | ||
| 正常对照组 | 184.1(181.7~186.4) | 174.3(172.4~176.6) | 183.5(180.3~186.1) | ||
| 项目 | 二项式拟合公式 | r值 | P值 |
|---|---|---|---|
| RBC计数 | Y=4.750-0.143X-0.003X2 | -0.418 | <0.001 |
| Hb | Y=152.3-6.039X+0.144X2 | -0.470 | <0.001 |
| RET# | Y=81.96-1.696X-0.050X2 | -0.398 | <0.001 |
| RBC-O | Y=4.979-0.175X+0.004X2 | -0.464 | <0.001 |
| MCHC | Y=335.4-2.878X+0.093X2 | -0.260 | <0.01 |
| RET-He | Y=33.94-0.389X-0.000 5X2 | -0.352 | <0.001 |
| RET-Y | Y=183.4-1.263X-0.009X2 | -0.352 | <0.001 |
| RDW-SD | Y=41.24+1.325X+0.037X2 | 0.399 | <0.001 |
| RDW-CV | Y=12.61+0.316X-0.007X2 | 0.440 | <0.001 |
| 项目 | 二项式拟合公式 | r值 | P值 |
|---|---|---|---|
| RBC计数 | Y=4.750-0.143X-0.003X2 | -0.418 | <0.001 |
| Hb | Y=152.3-6.039X+0.144X2 | -0.470 | <0.001 |
| RET# | Y=81.96-1.696X-0.050X2 | -0.398 | <0.001 |
| RBC-O | Y=4.979-0.175X+0.004X2 | -0.464 | <0.001 |
| MCHC | Y=335.4-2.878X+0.093X2 | -0.260 | <0.01 |
| RET-He | Y=33.94-0.389X-0.000 5X2 | -0.352 | <0.001 |
| RET-Y | Y=183.4-1.263X-0.009X2 | -0.352 | <0.001 |
| RDW-SD | Y=41.24+1.325X+0.037X2 | 0.399 | <0.001 |
| RDW-CV | Y=12.61+0.316X-0.007X2 | 0.440 | <0.001 |
| [1] | LIANG Y W, ZHU Y F, ZHANG R, et al. Incidence,prognosis,and risk factors of sepsis-induced cardiomyopathy[J]. World J Clin Cases, 2021, 9(31):9452-9468. |
| [2] |
LOFTUS T J, MIRA J C, STORTZ J A, et al. Persistent inflammation and anemia among critically ill septic patients[J]. J Trauma Acute Care Surg, 2019, 86(2):260-267.
DOI PMID |
| [3] | BISHT K, TAY J, WELLBURN R N, et al. Bacterial lipopolysaccharides suppress erythroblastic islands and erythropoiesis in the bone marrow in an extrinsic and G- CSF-,IL-1-,and TNF-independent manner[J]. Front Immunol, 2020, 11:583550. |
| [4] | KOU M, WANG L. Surface toll-like receptor 9 on immune cells and its immunomodulatory effect[J]. Front Immunol, 2023, 14:1259989. |
| [5] | LAM L K M, MURPHY S, KOKKINAKI D, et al. DNA binding to TLR9 expressed by red blood cells promotes innate immune activation and anemia[J]. Sci Transl Med, 2021, 13(616):eabj1008. |
| [6] |
JO Y H, KIM K, LEE J H, et al. Red cell distribution width is a prognostic factor in severe sepsis and septic shock[J]. Am J Emerg Med, 2013, 31(3):545-548.
DOI PMID |
| [7] | OLINDER J, EHINGER D, LILJENBORG E, et al. Plasma levels of hepcidin and reticulocyte haemoglobin during septic shock[J]. J Innate Immun, 2020, 12(6):448-460. |
| [8] | SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The third international consensus definitions for sepsis and septic shock(Sepsis-3)[J]. JAMA, 2016, 315(8):801-810. |
| [9] | 中国医疗保健国际交流促进会急诊医学分会, 中华医学会急诊医学分会, 中国医师协会急诊医师分会, 等. 中国“脓毒症早期预防与阻断”急诊专家共识[J]. 中华危重病急救医学, 2020, 32(5):518-530. |
| [10] | 安萌萌, 龚平. 脓毒症相关性贫血发病机制及治疗的研究进展[J]. 中华急诊医学杂志, 2018, 27(10):1175-1178. |
| [11] |
CORWIN H L, SURGENOR S D, GETTINGER A. Transfusion practice in the critically ill[J]. Crit Care Med, 2003, 31(12 Suppl):S668-S671.
DOI PMID |
| [12] | WEIMANN A, CREMER M, HERNÁIZ-DRIEVER P, et al. Delta-He,Ret-He and a new diagnostic plot for differential diagnosis and therapy monitoring of patients suffering from various disease-specific types of anemia[J]. Clin Lab, 2016, 62(4):667-677. |
| [13] |
BUORO S, MANENTI B, SEGHEZZI M, et al. Innovative haematological parameters for early diagnosis of sepsis in adult patients admitted in intensive care unit[J]. J Clin Pathol, 2018, 71(4):330-335.
DOI PMID |
| [14] | WANG A Y, MA H P, KAO W F, et al. Red blood cell distribution width is associated with mortality in elderly patients with sepsis[J]. Am J Emerg Med, 2018, 36(6):949-953. |
| [15] | DINKLA S, VAN EIJK L T, FUCHS B, et al. Inflammation-associated changes in lipid composition and the organization of the erythrocyte membrane[J]. BBA Clin, 2016, 5:186-192. |
| [16] | CHAN C Y, CHENG C F, SHUI H A, et al. Erythrocyte degradation,metabolism,secretion,and communication with immune cells in the blood during sepsis:a review[J]. Tzu Chi Med J, 2021, 34(2):125-133. |
| [17] | SABER M M, MONIR N, AWAD A S, et al. TLR9:a friend or a foe[J]. Life Sci, 2022, 307:120874. |
| [18] | HOTZ M J, QING D, SHASHATY M G S, et al. Red blood cells homeostatically bind mitochondrial DNA through TLR9 to maintain quiescence and to prevent lung injury[J]. Am J Respir Crit Care Med, 2018, 197(4):470-480. |
| [1] | YAO Lifeng, ZHANG Ling. Research progress on clinical significance of monocyte distribution width in infection and inflammatory diseases [J]. Laboratory Medicine, 2025, 40(5): 503-507. |
| [2] | LING Xiaoting, PAN Liqiu, HUANG Yunhua, WEI Yuanyuan, DENG Xiaohui, YE Lihua, LIN Faquan, HUANG Yifang. Establishment of machine learning discriminatory formulas for thalassemia and iron deficiency anemia based on red blood cell morphology and parameters [J]. Laboratory Medicine, 2025, 40(4): 365-371. |
| [3] | ZHANG Haoyang, LU Lin, ZONG Ming, HE Long, DING Yuanyuan, FAN Lieying. Diagnostic and predictive value of white blood cell population data in patients with sepsis [J]. Laboratory Medicine, 2025, 40(3): 271-277. |
| [4] | WANG Tiankai, LIU Lin, JIN Peipei, WANG Fang, DING Ning. Clinical value of new neutrophil parameter NEU-X,NEU-Y and NEU-Z in diagnosis of sepsis [J]. Laboratory Medicine, 2024, 39(7): 682-686. |
| [5] | LIU Xiaowen, SHAO Wenqi, ZHU Jing, YANG Jing, ZHANG Chunyan, PAN Baishen, WANG Beili, GUO Wei. Establishment of reference interval of serum ferritin in adults in Shanghai by indirect method [J]. Laboratory Medicine, 2024, 39(6): 524-529. |
| [6] | JIANG Jingjing, GU Ping, WANG Chengyun, ZHANG Fan, SHEN Huiying, PAN Qiuhui, WANG Jing. Changes and clinical significance of procalcitonin and coagulation function indicators in children with sepsis [J]. Laboratory Medicine, 2024, 39(6): 573-577. |
| [7] | LIANG Dong, MEI Yue, WANG Tengjiao, YU Dong. Characteristic of blood microbiota of postoperative sepsis based on cfDNA NGS [J]. Laboratory Medicine, 2023, 38(8): 753-759. |
| [8] | ZHAO Xiaomin, JIANG Xiaoyu, SHAN Kaili, SHAN Tieying, LIU Xiuzhen. Roles of Flt-3L,TF and 25(OH)D in iron deficiency anemia among infants and children [J]. Laboratory Medicine, 2022, 37(11): 1039-1043. |
| [9] | PAN Xilong, XU Zhiyuan, XIE Feng, LI Dan. Role of procalcitonin in the diagnosis of different sepsis [J]. Laboratory Medicine, 2021, 36(12): 1215-1218. |
| [10] | HU Senan, AI Honghong, YE Xuelian, CHENG Jiangyan. Relationship between complement 3,interleukin 35 and the severity and prognosis of sepsis [J]. Laboratory Medicine, 2021, 36(1): 25-29. |
| [11] | FU Jing, TU Xing. Serum high mobility group box-1 expression in patients with sepsis caused by bacteria and its clinical significant [J]. Laboratory Medicine, 2021, 36(1): 80-83. |
| [12] | ZHANG Hongxia, HAN Hong. Changes and roles of sST2,SF and hepcidin levels in patients with CHF and anemia [J]. Laboratory Medicine, 2020, 35(9): 912-916. |
| [13] | LU Jiacai, HUANG Ying, MO Yang, ZHOU Xiaofen, YAO Xin. Role of CD55,CD59 and FLAER combined determination for the diagnosis of PNH [J]. Laboratory Medicine, 2020, 35(6): 566-569. |
| [14] | TANG Lin, ZHANG Xiaojing, TANG Zhenhua. Investigation of gestational anemia in Shanghai,2016 [J]. Laboratory Medicine, 2020, 35(2): 116-119. |
| [15] | CHEN Shiyang, FU Xiaoying, XU Gang, LIN Zhenhu, LUO Meizhu, MAI Huirong, CHEN Yunsheng, LIU Sixi. Monitoring lymphocyte subsets after β-mediterranean anemia allogeneic hematopoetic stem cell transplantation in children [J]. Laboratory Medicine, 2019, 34(12): 1066-1071. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||